NCT04919434

Brief Summary

Main objective The intervention study IRECO aims to (1) modify habits of personal care product use for the participants and (2) evaluate the impact of those modification on urinary concentration for the following compounds: phthalates, phenols and glycol ether. Secondary objectives: The secondary objectives of this study aim to evaluate:

  1. 1.impact of modification of personal care product on the levels of biomarkers linked to exposure to environmental pollutant other than phthalates phenol and glycol ether (untargeted analysis) and biomarkers related to health (such as inflammatory biomarkers and oxidative stress).
  2. 2.hazard perception linked to the exposure to chemical product present in personal care product
  3. 3.barriers to change habits allowing to decrease exposure to environmental pollutant on short and long term as well as levers allowing to remove those barriers.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jun 2022Jun 2027

First Submitted

Initial submission to the registry

May 26, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 9, 2021

Completed
1 year until next milestone

Study Start

First participant enrolled

June 26, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2024

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2027

Expected
Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

2.1 years

First QC Date

May 26, 2021

Last Update Submit

April 8, 2026

Conditions

Keywords

intervention studychemical assessmentpersonal care product

Outcome Measures

Primary Outcomes (1)

  • Modification of exposure to phthalates, phenols and glycol ether

    Urinary concentration of phthalates, phenols and glycol ether will be measured in urine sample. Urinary concentration will be measured in the three phases of the study : before intervention (phase 1), during intervention (phase 2) and after intervention (phase 3). The level of urinary concentration will be compared between each phase : phase 1 versus phase 2 and phase 2 versus phase 3.

    follow-up 1 week

Secondary Outcomes (3)

  • Modification of exposure other than phthalates, phenols and glycol ether

    follow-up 1 week

  • Hazard perception linked to the exposure to chemical product present in personal care product

    during the follow-up week.

  • Barriers to change habits in the use of personal care product

    during the follow-up week and 2 months after the intervention

Study Arms (1)

Intervention

OTHER

Women will be asked NOT to use their own personal care product during the intervention. They will only have to use the substitute one given by the research team

Other: IRECO

Interventions

IRECOOTHER

During 5 days, women included in the study will have to only use personal care product distributed by the research team.

Intervention

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • be a women
  • be older than 18 and younger than 30
  • accept to not use or use only the substitute personal care product for 5 days
  • no know allergy to ingredients in personal care product
  • no skin or allergy disease
  • have a medical insurance
  • live in Grenoble area
  • speak french fluently
  • have a freezer to store the urine sample for a week

You may not qualify if:

  • being pregnant
  • working in a job manipulating personal care product
  • participating in an other study on cosmetics, personal care product, diet or any other study that may affect exposure to the studied chemicals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut pour l'avancée des biosciences IAB (U1209)/hôpital couple enfant du CHU Grenoble-Alpes

Grenoble, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2021

First Posted

June 9, 2021

Study Start

June 26, 2022

Primary Completion

July 16, 2024

Study Completion (Estimated)

June 25, 2027

Last Updated

April 9, 2026

Record last verified: 2026-04

Locations